Cyclophosphamide

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

39 API Suppliers, 21 USDMF, 5 CEP/COS, 6 EU WC, 18 NDC API, 22 Listed Suppliers

DEVELOPMENTS

270 Drug(s) in Development

270 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

INTERMEDIATES

3 Suppliers

3 Suppliers

DOSSIERs // Finished Dosage Formulations

135 Dossiers, 75 FDA Orange Book, 15 Europe, 6 Canada, 11 Australia, 6 South Africa, 22 Listed Dossiers

DRUG PRODUCT COMPOSITION

INJECTABLE;INJECTION - 100MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 1GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 200MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 25MG, CAPSULE;ORAL - 50MG

INJECTABLE;INJECTION - 100MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 1GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 200MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - 25MG
CAPSULE;ORAL - 50MG

RELATED EXCIPIENT COMPANIES

Suppliers, 20 Kerry, 17 Roquette, 17 SPI Pharma, 11 Microlex e.U, 10 Gangwal Healthcare, 9 Sigachi Industries, 4 ACG Worldwide, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 DFE Pharma, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 Gangwal Chemicals, 3 Lonza Capsugel, 3 Prachin Chemical, 3 Ingredion Pharma Solutions, 2 Nanjing Well Pharmaceutical, 2 Rochem International Inc, 2 BASF, 2 Seppic, 2 Pharmatrans-Sanaq, 2 Vasa Pharmachem, 1 Alcedo Pharmachem, 1 Qualicaps, 1 Shijiazhuang Huaxu Pharmaceutical, 1 DKSH, 1 Finar, 1 Minakem, 1 Ideal Cures Pvt Ltd, 1 NEWEDGE Overseas, 1 Jai Radhe Sales, 1 Pfanstiehl, 1 Chynops Pharma

EXCIPIENTS BY APPLICATIONS

64 Fillers, Diluents & Binders, 28 Direct Compression, 16 Chewable & Orodispersible Aids, 16 Lubricants & Glidants, 14 Taste Masking, 14 Co-Processed Excipients, 13 Thickeners and Stabilizers, 12 Granulation, 11 Disintegrants & Superdisintegrants, 8 Empty Capsules, 8 Coating Systems & Additives, 5 Controlled & Modified Release, 5 Parenteral, 5 Film Formers & Plasticizers, 2 Topical, 2 Emulsifying Agents, 2 API Stability Enhancers, 1 Solubilizers, 1 Rheology Modifiers